Neurogenics logo
Platform Opportunity

One technology. Multiple applications.

A platform positioned between established categories, built to move up the evidence ladder over the coming decade.

  1. LAYER 01

    Nutraceuticals

    Everyday nutrition and functional formats.

  2. LAYER 02

    Botanical Medical Foods

    Standardised bioactive compositions.

  3. LAYER 03

    Botanical Medical Drugs

    Regulated therapeutic candidates

  4. LAYER 04

    Future Medicines

    Long horizon therapeutic development.

  5. LAYER 05

    Innovative Platforms

    Novel delivery formats and technology extensions.

Applications

Five directions from a single technology base.

01

Cardiovascular Health

Vascular function is the first area of focus and the clearest route to independent evaluation.

02

Metabolic Health

Cardiometabolic pathways where inflammatory and vascular biology intersect.

03

Healthy Ageing

Healthspan applications built on mechanisms shared across diseases of ageing particularly Neurodegenerative Models.

04

Scientific Partnerships

Joint research programmes with universities, institutes and clinical academics.

05

Global Licensing

Territory, category and format licensing to ingredient, food and pharmaceutical partners.

Areas for collaboration
Therapeutic Pipeline

From food delivered bioactives to botanical therapeutics.

Neurogenics is developing a pipeline of botanical candidates across food delivered health, medical nutrition and botanical drug applications.

  1. CANDIDATE 01250 mg of flavanols

    NC-OX1

    Botanical antioxidant complex for oxidative stress reduction

    • Cocoa-derived polyphenol matrix
    • Targets endothelial oxidative load
    • Supports vascular function
    • Food-delivery compatible
    • High stability and bioavailability
  2. CANDIDATE 02500 mg of flavanols

    NC-CardioBlend

    Multi-botanical formulation for cardiometabolic support

    • Cocoa + plant peptides
    • Improves metabolic signalling
    • Reduces inflammatory stress
    • Designed for daily consumption
    • Early clinical feasibility underway
    • Regulatory pathway to be agreed
  3. CANDIDATE 03PRECLINICAL

    NC-DrugX

    Next-generation botanical drug targeting oxidative stress pathways

    • High-potency botanical extract
    • Drug-like pharmacokinetics
    • Cardiovascular and metabolic indications
    • Developed under botanical drug regulatory pathway
    • Preclinical development stage

Pipeline progression

  1. STAGE 01

    Botanical Medical Food

  2. STAGE 02

    Botanical Medical Food/Drug

  3. STAGE 03

    Botanical Drug

Why does this matter?

Single-product companies are constrained by one indication. A characterised platform technology can support multiple applications and multiple partners simultaneously.

Why now?

Global ingredient, food and pharmaceutical companies are actively seeking defensible, evidence-backed natural bioactives with credible supply routes.

Why Neurogenics?

Protected process technology, a platform architecture from the outset, and a UK industrial biotechnology base built for scale-up and export.